ストックスクリーナーアプリを入手
120.37
5.16%
-6.55
アフターアワーズ：
120.40
0.03
+0.02%
Illumina Inc (ILMN) 最新ニュース
Will DRAGEN v4.5’s ML-Powered Genomics Upgrade Reshape Illumina’s (ILMN) Precision Medicine Narrative? - Yahoo Finance
Unlocking Q1 Potential of Illumina (ILMN): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Illumina (ILMN) Q1 earnings report preview: What to look for - MSN
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
Prenatal Testing Services Market key players 2025-2031 : Illumina Inc, Centogene NV., Revvity, Inc. etc - openPR.com
Illumina, Inc. (ILMN) Stock Analysis: Unveiling Growth Potential With A Promising Upside - DirectorsTalk Interviews
Illumina, Inc. $ILMN Shares Sold by KLP Kapitalforvaltning AS - MarketBeat
Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility - Illumina
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
ILMN CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Illumina, Inc. (ILMN) Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - TMX Newsfile
Universal Beteiligungs und Servicegesellschaft mbH Sells 15,739 Shares of Illumina, Inc. $ILMN - MarketBeat
Human Microbiome Sequencing Technology Market Competitive - openPR.com
Omics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F - GlobeNewswire Inc.
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
AML Complexity Uncovered: - Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DNA Extraction, Isolation and Purification Market: Key Players - openPR.com
OVERSEA CHINESE BANKING Corp Ltd Decreases Stock Position in Illumina, Inc. $ILMN - MarketBeat
Gene Expression Analysis Market Set for Robust Growth to USD - openPR.com
Illumina Inc. (ILMN) – Pediatric Genomics Collaboration Bolsters Long-Term Growth Narrative Amid Mixed Historical ReturnsFast Rising Picks - Cổng thông tin điện tử tỉnh Tây Ninh
Belpointe Asset Management LLC Purchases Shares of 9,592 Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. (ILMN) Launches DRAGEN v4.5 Bioinformatics Suite, Expanding Addressable Market in Genomic Research and Clinical OncologyPost Announcement - Xã Thanh Hà
ILMN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
South America Next Generation Sequencing eDNA Biomonitoring - openPR.com
Metagenomics Market Key Companies AnalysisMerck KGaA, Thermo - openPR.com
Pharmacogenomics Market Leading Companies | F. Hoffmann-la - openPR.com
Illumina Inc. stock underperforms Monday when compared to competitors - MarketWatch
Tsinghua University brings hands-on multiomics training to young scientists - Illumina
UPS, Netflix, BlackRock And A Health Care Stock On CNBC's 'Final Trades'BlackRock (NYSE:BLK), Illumina - Benzinga
Illumina, Inc. (ILMN) Stock Analysis: Balancing Innovation In Genomics With Market Volatility - DirectorsTalk Interviews
Fortis Capital Advisors LLC Invests $1.26 Million in Illumina, Inc. $ILMN - MarketBeat
Asset Management One Co. Ltd. Grows Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
KBC Group NV Has $5.90 Million Stake in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. Common Stock Ex-distribution When-Issued (ILMNV) - Minichart
Behavioral Patterns of ILMN and Institutional Flows - Stock Traders Daily
Illumina, Inc. $ILMN Shares Acquired by Cwm LLC - MarketBeat
Illumina Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Illumina (ILMN), Labcorp (LH) expand precision oncology NGS collaboration - MSN
ILMN Stock Price, Quote & Chart | ILLUMINA INC (NASDAQ:ILMN) - ChartMill
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows - PR Newswire
Robeco Institutional Asset Management B.V. Trims Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Illumina Inc. stock (US4523271090): Why does its genomics dominance matter more now for U.S. investo - AD HOC NEWS
Illumina’s Pediatric Genomics Push Tests Long Term Growth Narrative - Yahoo Finance
Illumina partners with D3b on pediatric genomic data initiative By Investing.com - Investing.com Canada
How Investors Are Reacting To Illumina (ILMN) Board Turnover And Expanded Labcorp Precision Oncology Partnership - simplywall.st
Illumina partners with D3b on pediatric genomic data initiative - Investing.com
Illumina Partners with D3b to Advance Pediatric Cancer Research - Intellectia AI
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease - PR Newswire
2.94%
大文字化:
|
ボリューム (24 時間):